Eicosanoids, menstruation and menstrual disorders
Eicosanoids are synthesized in uterine tissues and play significant roles in normal physiological uterine functions as well as pathological disturbances, particularly menstruation and menstrual disorders.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews evidence that eicosanoids—especially prostaglandins synthesized in the endometrium and acting on uterine tissues—play major roles in normal uterine physiology and in pathological disturbances, with particular emphasis on menstruation and “menstrual disorders.” It synthesizes findings from human and animal studies measuring prostaglandin levels, release from uterine tissues during the menstrual cycle, and receptor/binding profiles, and it discusses how these mediators may relate to processes such as uterine contractility and menstrual blood loss, including in dysmenorrhea and dysfunctional uterine bleeding. A stated limitation of the review format is that it is largely based on accumulating disparate mechanistic and observational studies rather than presenting new controlled data. Relevance to endometriosis: the review is centrally focused on menstruation physiology and menstrual disorders, which are closely related to the endometriosis-associated experience of cyclical pelvic pain and abnormal bleeding, though the provided text does not explicitly discuss endometriosis or adenomyosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Anaprox in dysmenorrhea: Reduction of pain and intrauterine pressure via openalex
- Control of bleeding due to IUDs by a prostaglandin biosynthesis inhibitor. via openalex
- Cul-de-sac fluid in women with endometriosis: fluid volume and prostanoid concentration during the proliferative phase of the cycle—days 8 to 12 via openalex
- EFFECT OF ACETYLSALICYLIC ACID, PARACETAMOL AND PLACEBO ON PAIN AND BLOOD LOSS IN DYSMENORRHEIC WOMEN via openalex
- EFFECTS OF NIFEDIPINE ON MYOMETRIAL ACTIVITY AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA via openalex
- EFFECTS OF TERBUTALINE ON MYOMETRIAL ACTIVITY, UTERINE BLOOD FLOW, AND LOWER ABDOMINAL PAIN IN WOMEN WITH PRIMARY DYSMENORRHOEA via openalex
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women via openalex
- Endometrial and Myometrial Prostaglandin Release during the Menstrual Cycle in Relation to Menstrual Blood Loss* via openalex
- Levels of prostaglandins F2α and E2 in human endometrium during the menstrual cycle via openalex
- Levels of prostaglandins in human endometrium during the normal menstrual cycle via openalex
- Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. via openalex
- MORPHOLOGY OF HAEMOSTASIS IN MENSTRUAL ENDOMETRIUM via openalex
- Naproxen sodium, aspirin, and placebo in primary dysmenorrhea via openalex
- New observations on the physiology of menstruation. via openalex
- Peritoneal fluid 6-keto prostaglandin F1α levels in women with endometriosis via openalex
- Peritoneal fluid thromboxane B2 and 6-keto-prostaglandin F1α in endometriosis via openalex
- Presence of gap junctions in the myometrium of women during various stages of menstruation via openalex
- Prostaglandin biosynthesis inhibitors and endometriosis via openalex
- Prostaglandin F in human endometriotic tissue via openalex
- Prostaglandins in primary dysmenorrhea via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- STUDIES IN THE INVOLVEMENT OF PROSTAGLANDINS IN UTERINE SYMPTOMATOLOGY AND PATHOLOGY via openalex
- THE EFFECT OF DIFFERENT PROSTAGLANDINS ON HUMAN MYOMETRIUM IN VITRO. via openalex
- THE MICROVASCULATURE OF COMMON UTERINE ABNORMALITIES, OTHER THAN FIBROIDS via openalex
- The Myometrial Response to Intra‐Uterine Administration of PGF<sub>2α</sub> and PGE<sub>2</sub> in Dysmenorrheic Women via openalex
- W2000018061 via openalex
- W2002213869 via openalex
- W2006319547 via openalex
- W2011288992 via openalex
- W2012165536 via openalex
- W2013457347 via openalex
- W2013589363 via openalex
- W2016589373 via openalex
- W2016862873 via openalex
- W2017162336 via openalex
- W2018467822 via openalex
- W2019141350 via openalex
- W2022742042 via openalex
- W2029159327 via openalex
- W2033526345 via openalex
- W2034750793 via openalex
- W2036413582 via openalex
- W2037691565 via openalex
- W2040634552 via openalex
- W2041118356 via openalex
- W2042622497 via openalex
- W2045624175 via openalex
- W2046468597 via openalex
- W2068503311 via openalex
- W2071386031 via openalex
- W2080950545 via openalex
- W2081455781 via openalex
- W2083717098 via openalex
- W2086246570 via openalex
- W2087164457 via openalex
- W2087438806 via openalex
- W2088098780 via openalex
- W2092426612 via openalex
- W2095046700 via openalex
- W2114800362 via openalex
- W2118569178 via openalex
- W2146863445 via openalex
- W2283472795 via openalex
- W2284658387 via openalex
- W2298577506 via openalex
- W2329841599 via openalex
- W2395308611 via openalex
- W2397927045 via openalex
- W2398301307 via openalex
- W2407270181 via openalex
- W2409076834 via openalex
- W2409622025 via openalex
- W2413839422 via openalex
- W2414650776 via openalex
- W2416410587 via openalex
- W2416440242 via openalex
- W2418304456 via openalex
- W2418754503 via openalex
- W2419208215 via openalex
- W2422882427 via openalex
- W2426187966 via openalex
- W2548494496 via openalex
- W2610909957 via openalex
- W2677106123 via openalex
- W2885300929 via openalex
- W3024096772 via openalex
- W3041968289 via openalex
- W4285719527 via openalex
- W4299952610 via openalex
- W6607729374 via openalex
- W3470488 via openalex
- W6649514666 via openalex
- W136202102 via openalex
- W191591924 via openalex
- W584944875 via openalex
- W602929082 via openalex
- W653439884 via openalex
- W1497675019 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00